Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

ClinicalTrials.gov ID: NCT00004001

Public ClinicalTrials.gov record NCT00004001. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 5:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Docetaxel and Estramustine Versus Mitoxantrone and Prednisone for Advanced, Hormone Refractory Prostate Cancer

Study identification

NCT ID
NCT00004001
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
770 participants

Conditions and interventions

Interventions

  • docetaxel Drug
  • estramustine Drug
  • mitoxantrone Drug
  • prednisone Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 1999
Primary completion
Jun 30, 2006
Completion
Dec 31, 2006
Last update posted
Feb 24, 2014

1999 – 2007

United States locations

U.S. sites
16
U.S. states
9
U.S. cities
16
Facility City State ZIP Site status
CCOP - Scottsdale Oncology Program Scottsdale Arizona 85259-5404
Mayo Clinic Jacksonville Florida 32224
CCOP - Illinois Oncology Research Association Peoria Illinois 61602
CCOP - Carle Cancer Center Urbana Illinois 61801
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016
Siouxland Hematology-Oncology Sioux City Iowa 51101-1733
Mayo Clinic Cancer Center Rochester Minnesota 55905
CentraCare Health Plaza Saint Cloud Minnesota 56303
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68106
Medcenter One Health System Bismarck North Dakota 58501
CCOP - Merit Care Hospital Fargo North Dakota 58122
Altru Health System Grand Forks North Dakota 58201
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001
Rapid City Regional Hospital Rapid City South Dakota 57709
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00004001, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 24, 2014 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00004001 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →